Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medicalgorithmics S.A. Director's Dealing 2023

Mar 27, 2023

5705_rns_2023-03-27_750ab8f9-0dde-465f-af4a-bb943a0362b4.html

Director's Dealing

Open in viewer

Opens in your device viewer

Notifications of transactions of personsdischarging managerial responsibilities received in accordance withArticle 19 of the MAR Regulation

Current Report No. 9/2023

Date: 27.03.2023 r.

Legal basis: Article 19(3) of the MAR Regulation -information on transactions performed by persons discharging managerialresponsibilities

The Management Board of Medicalgorithmics S.A. (the _quot;Company_quot;)informs, pursuant to Article 19(3) of Regulation (EU) No 596/2014 of theEuropean Parliament and of the Council of 16 April 2014 on market abuse(market abuse regulation) and repealing Directive 2003/6/EC of theEuropean Parliament and of the Council and Commission Directives2003/124/EC, 2003/125/EC and 2004/72/EC (_quot;MAR Regulation_quot;),that on 27 March 2023 the Company received from persons dischargingmanagerial responsibilities: Mr. Jarosław Jerzakowski - Member of theManagement Board, Mr. Maciej Gamrot - Member of the Management Board forFinance and Mr. Przemysław Tadla - Member of the Management Board,notifications of purchasing in total 9.193 Company's shares on theWarsaw Stock Exchange market, as referred to in Article 19 Section 1 ofthe MAR Regulation.

According to the notifications received by the Company:

1)_#160;_#160;_#160;1)Mr. Jarosław Jerzakowski - Member of theManagement Board of the Company acquired in total 3,014 Company shares,

2)_#160;_#160;_#160;2)Mr. Maciej Gamrot - Member of theManagement Board for Finance acquired in total 3,175 Company shares,

3)_#160;_#160;_#160;3)Mr. Przemysław Tadla - Member of theManagement Board of the Company acquired in total 3,004 Company shares.

The notifications are attached to this report